Detalles de la búsqueda
1.
Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial.
Lancet;
395(10234): 1423-1433, 2020 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32197105
2.
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial.
Lancet;
384(9951): 1358-65, 2014 Oct 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-25018116
3.
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet Glob Health;
12(2): e257-e270, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38245116
4.
Acute hepatic failure among hospitalized Thai children.
Southeast Asian J Trop Med Public Health;
44(1): 50-3, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23682437
5.
Immunogenicity of a human rotavirus vaccine (RIX4414) after storage at 37 °C for seven days.
Hum Vaccin;
7(1): 74-80, 2011 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21228629
6.
Cross-clade immunogenicity and antigen-sparing with an AS03(A)-adjuvanted prepandemic influenza vaccine in a Thai population.
J Med Assoc Thai;
94(8): 916-26, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21863672
7.
Safety and immunogenicity of a single dose of a tetravalent dengue vaccine with two different serotype-2 potencies in adults in Singapore: A phase 2, double-blind, randomised, controlled trial.
Vaccine;
38(6): 1513-1519, 2020 02 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31843269
8.
Liver function test results and outcomes in children with acute liver failure due to dengue infection.
Southeast Asian J Trop Med Public Health;
40(1): 47-53, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19323033
9.
Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children.
Am J Trop Med Hyg;
78(3): 426-33, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18337339
10.
Primary vaccination with a new heptavalent DTPw-HBV/Hib-Neisseria meningitidis serogroups A and C combined vaccine is well tolerated.
Int J Infect Dis;
12(1): 88-97, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17716936
11.
The immunological response of Thai infants to haemophilus influenzae type B polysaccharide-tetanus conjugate vaccine co-administered in the same syringe with locally produced diphtheria-tetanus-pertussis vaccine.
J Med Assoc Thai;
90(7): 1330-6, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17710973
12.
Safety and immunogenicity of an intramuscular quadrivalent influenza vaccine in children 3 to 8 y of age: A phase III randomized controlled study.
Hum Vaccin Immunother;
12(12): 3072-3078, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27565435
13.
Lot-to-lot consistency of a tetravalent dengue vaccine in healthy adults in Australia: a randomised study.
Vaccine;
33(39): 5127-34, 2015 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-26279339
14.
Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial.
Vaccine;
33(21): 2485-92, 2015 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25843270
15.
Flexibility in the administration schedule of varicella vaccination in healthy adolescents and young adults.
Asian Pac J Allergy Immunol;
20(4): 241-5, 2002 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12744625
16.
Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety.
Pediatr Infect Dis J;
33(6): 643-9, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24717964
17.
Concomitant administration of live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) and measles, mumps, rubella (MMR) vaccine: randomized study in toddlers in Taiwan.
Vaccine;
32(41): 5363-9, 2014 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24631095
18.
Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2-11 years in Malaysia: a randomized, placebo-controlled, Phase III study.
Vaccine;
31(49): 5814-21, 2013 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-24135573
19.
Dengue and other common causes of acute febrile illness in Asia: an active surveillance study in children.
PLoS Negl Trop Dis;
7(7): e2331, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23936565
20.
Immunogenicity of a live-attenuated human rotavirus RIX4414 vaccine with or without buffering agent.
Hum Vaccin;
6(3)2010 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-20220306